Oramed Pharmaceuticals Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BML CAPITAL MANAGEMENT, LLC | 11/05/2024 | 2.19 M | $5.33 M | 62.06% | 5.41% |
MURCHINSON LTD. | 11/14/2024 | 1.71 M | $4.17 B | 0.52% | 4.23% |
BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 828,331 | $2.02 M | 0.40% | 2.05% |
RATHBONES GROUP PLC | 11/13/2024 | 289,803 | $707,119 | 0.00% | 0.72% |
TWO SIGMA ADVISERS, LP | 11/14/2024 | 255,600 | $623,664 | -1.35% | 0.63% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 245,300 | $598,532 | 6.28% | 0.61% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 172,192 | $420,148 | -0.61% | 0.43% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 141,683 | $345,707 | -5.78% | 0.35% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 134,373 | $327,871 | 6.79% | 0.33% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 111,519 | $272,106 | 100.00% | 0.28% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 92,009 | $224,502 | 100.00% | 0.23% |
SQUAREPOINT OPS LLC | 11/14/2024 | 83,355 | $203,386 | 1.95% | 0.21% |
STATE STREET CORP | 11/14/2024 | 60,056 | $146,537 | 1.34% | 0.15% |
JANE STREET GROUP, LLC | 11/15/2024 | 58,300 | $142,252 | 3.98% | 0.14% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 48,805 | $119,084 | 55.08% | 0.12% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 46,667 | $113,867 | 139.85% | 0.12% |
MORGAN STANLEY | 11/14/2024 | 44,653 | $108,952 | -1.72% | 0.11% |
LPL FINANCIAL LLC | 11/08/2024 | 38,681 | $94,382 | -4.42% | 0.10% |
UBS GROUP AG | 11/14/2024 | 28,184 | $68,769 | 203.35% | 0.07% |
PNC FINANCIAL SERVICES GROUP, INC. | 11/08/2024 | 26,200 | $63,928 | 0.00% | 0.06% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 25,455 | $62,110 | 0.00% | 0.06% |
WELLS FARGO & COMPANY/MN | 11/13/2024 | 25,086 | $61,209 | -1.95% | 0.06% |
XTX TOPCO LTD | 11/14/2024 | 24,716 | $60,307 | 59.73% | 0.06% |
MARSHALL WACE, LLP | 11/14/2024 | 22,527 | $54,966 | 100.00% | 0.06% |
CITADEL ADVISORS LLC | 11/14/2024 | 21,402 | $52,221 | 100.00% | 0.05% |
AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 19,591 | $47,802 | 0.00% | 0.05% |
SAVVY ADVISORS, INC. | 11/05/2024 | 18,810 | $45,896 | 0.00% | 0.05% |
ATRIA INVESTMENTS, INC | 11/01/2024 | 18,004 | $43,930 | 8.39% | 0.04% |
SAGE CAPITAL MANAGEMENT, LLC | 10/30/2024 | 16,750 | $40,870 | 0.00% | 0.04% |
PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2024 | 14,435 | $35,221 | 100.00% | 0.04% |
BARCLAYS PLC | 11/19/2024 | 13,239 | $32,000 | 0.00% | 0.03% |
ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 13,118 | $32,008 | -20.10% | 0.03% |
N.E.W. ADVISORY SERVICES LLC | 10/31/2024 | 12,360 | $30,158 | 0.00% | 0.03% |
JOURNEY STRATEGIC WEALTH LLC | 11/12/2024 | 12,278 | $29,958 | 11.62% | 0.03% |
VIRTU FINANCIAL LLC | 11/20/2024 | 12,123 | $30,000 | -17.95% | 0.03% |
ALTSHULER SHAHAM LTD | 11/14/2024 | 12,020 | $29.38 M | 0.00% | 0.03% |
CLOSE ASSET MANAGEMENT LTD | 11/12/2024 | 11,400 | $28,000 | 0.00% | 0.03% |
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 10/24/2024 | 11,300 | $27,572 | -0.88% | 0.03% |
MARINER, LLC | 11/13/2024 | 10,544 | $25,727 | 0.00% | 0.03% |
GLASS JACOBSON INVESTMENT ADVISORS LLC | 11/15/2024 | 10,540 | $25,718 | 0.00% | 0.03% |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/14/2024 | 8,826 | $21,535 | 0.00% | 0.02% |
TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 7,997 | $19,512 | -35.45% | 0.02% |
ROYAL BANK OF CANADA | 11/14/2024 | 4,227 | $10,000 | -16.81% | 0.01% |
CITADEL ADVISORS LLC | 11/14/2024 | 4,000 | $9,760 | 100.00% | 0.01% |
ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 3,849 | $9,391 | 0.00% | 0.01% |
CITADEL ADVISORS LLC | 11/14/2024 | 2,100 | $5,124 | 100.00% | 0.01% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/12/2024 | 1,575 | $3,843 | 0.00% | 0.00% |
FMR LLC | 11/13/2024 | 1,500 | $3,660 | 100.00% | 0.00% |
CITY HOLDING CO | 10/08/2024 | 1,070 | $2,610 | 0.00% | 0.00% |
MCILRATH & ECK, LLC | 11/19/2024 | 1,000 | $2,440 | -50.00% | 0.00% |
Oramed Pharmaceuticals Inc.institutional Ownership - FAQ's
During the previous two years, 83 institutional investors and hedge funds held shares of Oramed Pharmaceuticals Inc.. The most heavily invested institutionals were:
BML Capital Management, LLC: 2.19 M
Murchinson Ltd.: 1.71 M
BOOTHBAY FUND MANAGEMENT, LLC: 828,331
Rathbones Group PLC: 289,803
TWO SIGMA ADVISERS, LP: 255,600
RENAISSANCE TECHNOLOGIES LLC: 245,300
17.21% of Oramed Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 8.31 M shares in the last 24 months. This purchase volume represents approximately $20.28 M in transactions.